Mable (Neurolytic Healthcare)

Mable (Neurolytic Healthcare)

Signal active

Organization

Contact Information

Overview

Neurolytic Healthcare provides personalized medicine for neurological conditions. Neurolytic Healthcare collects and extracts insights from a combination of genetic and biomarker data to enhance diagnosis and help clinicians decide on optimal treatment strategies for neurological conditions.

The company delivers digitally and genomically-driven medical devices to improve the current treatment of migraine and other neurological disorders, including a diagnostic support tool, pharmacogenetic test, and a mobile app for migraine event prediction.

About

Industries

Health Care, Medical, Neuroscience

Founded

2019

Employees

11-50

Headquarters locations

Europe

Social

N/A

Profile Resume

Mable (Neurolytic Healthcare) headquartered in Europe, operates in the Health Care, Medical, Neuroscience sector. The company focuses on Health Care and has secured $156.0M in funding across 48 round(s). With a team of 11-50 employees, Mable (Neurolytic Healthcare) is actively contributing to advancements in Health Care. Their latest funding round, Pre Seed Round - Mable (Neurolytic Healthcare), raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.

Employees

N/A

Funding Rounds

Funding rounds

4

Investors

2

Lead Investors

0

Total Funding Amount

$3.3M

Details

3

Mable (Neurolytic Healthcare) has raised a total of $3.3M in funding over 3 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2021Seed50.0K
2022Seed3.2M
2022Seed

Investors

Mable (Neurolytic Healthcare) is funded by 12 investors.

Investor NameLead InvestorFunding RoundPartners
Inaki Berenguer-FUNDING ROUND - Inaki Berenguer3.2M
Y Combinator-FUNDING ROUND - Y Combinatorundefined
Mable (Neurolytic Healthcare)-FUNDING ROUND - Mable (Neurolytic Healthcare)undefined
Illumina-FUNDING ROUND - Illuminaundefined

Recent Activity

There is no recent news or activity for this profile.